[With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab]

Enferm Infecc Microbiol Clin. 2012 Feb;30(2):109-10. doi: 10.1016/j.eimc.2011.10.013. Epub 2011 Dec 22.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Complement C5 / antagonists & inhibitors
  • Female
  • Fever / etiology
  • Hemoglobinuria, Paroxysmal / complications*
  • Hemoglobinuria, Paroxysmal / drug therapy
  • Hemoglobinuria, Paroxysmal / immunology
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Meningococcal Infections / etiology*
  • Meningococcal Vaccines
  • Middle Aged
  • Polysaccharides, Bacterial
  • Skin Diseases, Bacterial / etiology*
  • Vasculitis / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement C5
  • Immunosuppressive Agents
  • Mencevax AC
  • Meningococcal Vaccines
  • Polysaccharides, Bacterial
  • eculizumab